Clinical Trial Update: Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating Th-1 dendritic cell immunotherapy in combination with standard chemotherapy for pancreatic adenocarcinoma; recruitment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Adenosquamous Carcinoma
• Pancreatic Cancer

Drugs mentioned

• Th-1 Dendritic Cell Immunotherapy (Th-1 dendritic cell immunotherapy)

Snippet

Sponsor: Diakonos Oncology Corporation | Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 1 | Status: RECRUITING